Patient–ventilator synchrony is crucial for effective mechanical ventilation, yet asynchrony is common and often under-recognized, with early signs requiring careful waveform interpretation. In this Q&A, John Davies outlines practical approaches to identifying and managing asynchrony, highlighting missed patterns such as false triggering and cycle asynchrony, and offering strategies to troubleshoot triggering, inspiratory flow, and cycling issues, alongside considerations for sedation and ongoing patient assessment.
Innovation in pulmonary hypertension does not happen in isolation. It requires coordinated global effort, cross-sector collaboration, and a willingness to confront long-standing clinical challenges with fresh thinking. That is precisely the ambition behind the Innovative Drug Discovery Initiative (IDDI) Workstreams, a flagship initiative of the Pulmonary Vascular Research Institute (PVRI).
The PVRI 2026 Congress in Dublin marked not only the return of a global gathering of pulmonary vascular specialists, but also a significant milestone—the 20th anniversary of the Pulmonary Vascular Research Institute (PVRI). Under the theme “Celebrating 20 Years of Progress & Innovation,” the meeting offered an opportunity to reflect on 2 decades of scientific advancements, while looking ahead to the future of pulmonary vascular research and care.
As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchRESPIRATORY. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the respiratory community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.
The CHEST 2025 annual meeting brought together pulmonary, critical care, and sleep medicine experts to share emerging science, clinical insights, and forward-looking innovations shaping respiratory care. Through focused conversations with leaders across the field, these interviews highlight practical, practice-ready insights that clinicians can bring directly to patient care.
Smoking cessation is essential in chronic respiratory disease, yet clinicians must navigate evolving evidence, diverse patient needs, and persistent inequities in care. In this Q&A, Dr Humayun Anjum discusses current data on e-cigarettes, practical strategies for individualising cessation support, and approaches to embedding health equity into clinical practice. He highlights policy, community, and clinical interventions that expand access to evidence-based resources, particularly for underserved populations.
CHEST 2025 delivered a dynamic, multidisciplinary program showcasing advances in pulmonary, critical-care, and thoracic medicine. Dr Jean Elwing highlights the most impactful PH-focused sessions, including immersive hemodynamic and imaging training, discussions on integrating sotatercept into PAH care, efforts to address disparities in PH care, and key updates at the intersection of transplant medicine and pulmonary hypertension.
touchRESPIRATORY is delighted to welcome Dr S Shahzad Mustafa to our Editorial Board. Dr Mustafa serves as the Division Head of Allergy, Immunology, and Rheumatology at Rochester Regional Health, where he provides care to both adult and paediatric patients. His ...
As the therapeutic landscape for fibrotic interstitial lung diseases (ILDs) continues to evolve, new trials are redefining targeted treatment and precision medicine approaches. In this Q&A, Dr Tejaswini Kulkarni discusses her CHEST 2025 presentation, highlighting emerging therapeutic targets, the role of biomarkers, recruitment challenges, and innovative trial designs shaping the future of fibrotic ILD research.
Positive airway pressure (PAP) therapy is the standard treatment for obstructive sleep apnea (OSA), but many patients struggle with adherence due to discomfort or intolerance. This interview with Dr Carolyn D’Ambrosio explores the key factors driving PAP nonadherence, practical strategies to improve compliance, promising alternative therapies, and emerging innovations aimed at personalizing treatment for challenging cases.
Allergic rhinitis is a common and often underdiagnosed condition that can impact asthma control, sleep, and daily functioning. In this Q&A, Dr Syed Shahzad Mustafa discusses his CHEST 2025 presentation, reviewing first-line therapies, allergen avoidance strategies, and the evolving role of immunotherapy and biologics, offering practical guidance for clinicians to optimize patient care in 2025.
As part of our Future Leaders series, we spoke with Dr Amy Wolfe, Director of the LSUHSC-Wetmore TB Clinic and Assistant Professor of Medicine at LSUHSC in New Orleans. A specialist in pulmonary and critical care medicine, Dr Wolfe shares how her early experiences in post-Katrina New Orleans inspired her focus on health equity. She discusses the challenges of treating TB in underserved communities, the importance of wraparound care, and promising innovations in pulmonology—from AI-based diagnostics to expanded access to pulmonary rehabilitation and lung cancer screening.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.